Discover
BioTech Nation ... with Dr. Moira Gunn
Treating the Untreatable in Rheumatoid Arthritis! Rob Armstrong, CEO, Artax Biopharma

Treating the Untreatable in Rheumatoid Arthritis! Rob Armstrong, CEO, Artax Biopharma
Update: 2025-10-29
Share
Description
40% of all rheumatoid arthritis patients do not respond to any of the current drugs. Rob Armstrong, CEO of Artax Biopharma, aims to bring new hope for those patients who've been left without effective treatment options.
Comments
In Channel






















